by ELIXIR Europe
Data. Is it all about technology, engineering or coding? We often don't see the immediate impact on other fields. But life sciences require data to advance. Join pioneers, entrepreneurs, investors and academics to discover the power and influence of data in medicine, genomics, biodiversity, marine sciences... When data meets know-how in the life sciences, we immerse ourselves in a different world – bioinformatics. Supported by ELIXIR Europe
Language
🇺🇲
Publishing Since
10/15/2020
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
June 23, 2021
In the latest Data for Life podcast, Hannes and Kathi talk to Abel, a bioinformatician, serial entrepreneur, investor, mentor, and open science enthusiast. He has been living the Europe dream – a Spanish born, French-educated and British-inspired entrepreneur. Exploiting open research data, Abel built a thriving bioinformatics business.
February 4, 2021
How can history studies prepare you for a career in bioinformatics? Why has Finland become a hub for genomics ventures? What is the current state of data quality in the life sciences, and how does this affect ventures? In this episode, Kathi and Hannes will move to Europe’s North to find the answers to these pressing questions, with Hans Garritzen from Medisapiens. The Finnish company provides clients with a digital health platform to leverage big biomedical data from public and private domains.
November 25, 2020
Hannes and Kathi welcome Maria Chatzou, CEO and Co-Founder of drug discovery startup Lifebit to the first interview of the Innovation series. In this episode, they explore Cambridge, one of the most important ecosystems for biodata-centred businesses and unveil Maria’s experience in this competitive fast-moving industry — as both a successful bioinformatician and an entrepreneur.
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
Data. Is it all about technology, engineering or coding? We often don't see the immediate impact on other fields. But life sciences require data to advance.
Join pioneers, entrepreneurs, investors and academics to discover the power and influence of data in medicine, genomics, biodiversity, marine sciences...
When data meets know-how in the life sciences, we immerse ourselves in a different world – bioinformatics.
Supported by ELIXIR Europe
This podcast updates daily.
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Yes, this podcast regularly features guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.